RFL
Rafael Holdings, Inc.
NYSE · Real Estate · Real Estate - Services · US
$2.56
+3.64%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−3.5x
Market Cap
$133.12M
MomentumView details →
1D Return
+3.64%
YTD Return
+118.22%
RSI (14)
64.4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−3.5x
Market Cap
$133.12M
RSI (14)
64.4
MomentumView details →
1D Return
+3.64%
YTD Return
+118.22%
SummaryUpdated Apr 1, 2026
Rafael Holdings, Inc. (NASDAQ:RFL) is a dual-purpose investment company founded in 2017 and publicly traded since March 2018. The company operates as a holding entity with interests in two distinct sectors: pharmaceutical development through its subsidiary Rafael Pharmaceuticals, and commercial real estate assets. Headquartered in Newark, New Jersey, Rafael Holdings represents an unusual corporate structure that combines biotech investment with real estate operations, creating a diversified investment vehicle for shareholders seeking exposure to both high-risk pharmaceutical development and stable real estate income.
Similar companies
Oriental Explorer Holdings Limited00430.HKRedsun Services Group Limited01971.HKHopefluent Group Holdings Limited00733.HKWenling Zhejiang Measuring and Cutting Tools Trading Centre Company Limited01379.HKXinji Shaxi Group Co., Ltd03603.HKGlobal Digital Creations Holdings Limited08271.HKFind similar companies →
Latest newsMore news →